APOL1 and vitiligo: This analysis showed peroxiredoxin-6 (PRDX6) and apolipoprotein L1 (APOL1) to be downregulated in patients with progressive and stable vitiligo compared to healthy controls, with in both cases the protein being more downregulated in progressive vitiligo compared to stable vitiligo.